Pathogenesis of Paradoxical Alopecia Areata During Dupilumab Therapy: What Is Known and Unknown

    Eric McMullen, Parsa Abdi, Iryna Savinova, Jeffrey Donovan
    Studysummary This study found that in patients with alopecia areata and atopic dermatitis, 61.5% showed improvement with dupilumab treatment, but 38.5% experienced worsened or new-onset alopecia areata, with higher baseline IgE levels linked to better responses.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →